呼吸道内视镜治疗设备市场 - 全球产业规模、份额、趋势、机会和预测，按设备、按最终用户、按专家、按地区和竞争进行细分，2020-2030 年预测

2024 年全球呼吸内视镜治疗设备市场价值为 14.5 亿美元，预计在预测期内将强劲成长，到 2030 年的复合年增长率为 5.33%。 COVID-19 疫情最初对呼吸设备市场产生了重大影响。然而，由于政府的措施和政策以及公司为弥补不足而采取的策略发展，呼吸设备市场大幅成长。例如，2021年5月，全球基金核准7,500万美元快速资金，支持印度因应新冠疫情危机。这笔新资金帮助印度购买氧气浓缩器和变压吸附（PSA）氧气设备，以帮助满足该国中期医用氧气需求。因此，由于COVID-19病例激增，对呼吸设备的需求增加，从而推动了市场的成长。然而，随着 COVID-19 病例的减少和疫情加速了呼吸设备的使用，预计所研究的市场在研究期间将呈现稳定成长。例如，根据世界卫生组织的数据，肺癌是全球癌症死亡的主要原因，其中85%的病例是吸烟造成的。对高风险族群进行早期筛检可以提高存活率，而烟草控制和减少环境风险因素等主要预防措施对于降低发病率和挽救生命至关重要。

主要市场驱动因素

呼吸系统疾病盛行率上升

主要市场挑战

呼吸内视镜治疗设备成本高昂

主要市场趋势

微创技术的进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球呼吸内视镜治疗设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按设备（诊断设备、治疗设备）
  • 依最终使用者（週边血管介入、血管内介入、心臟、介入放射学、静脉、其他）
  • 按专科医师（医院、诊断中心、门诊手术中心）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
• 按设备
• 按最终用户
• 由专家
• 按地区

第六章：北美呼吸道内视镜治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲呼吸道内视镜治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太呼吸内视镜治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲呼吸内视镜治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲呼吸内视镜治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 合併与收购
• 产品发布

第 13 章：全球呼吸内视镜治疗设备市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Fujifilm Holdings Corporation.
• Medtronic plc.
• Johnson & Johnson.
• Smith & Nephew Plc.
• Stryker corporation.
• Olympus corporation.
• Hoya corporation.
• Steris Healthcare.
• Conmed corporation.
• Boston Scientific corporation.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Respiratory Endotherapy Devices Market was valued at USD 1.45 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2030. The COVID-19 pandemic had a substantial impact on the respiratory devices market initially. However, the respiratory device market grew significantly as a result of government initiatives and policies, as well as the company's strategic developments to overcome the shortfall. For instance, in May 2021, the Global Fund approved USD 75 million in fast-track funding to support India's response to the COVID-19 crisis. This new funding helped India purchase oxygen concentrators and pressure swing adsorption (PSA) oxygen plants to help meet the country's medium-term medical oxygen needs. Hence, due to the surge in COVID-19 cases, the demand for respiratory devices increased, thereby fueling the growth of the market. However, as COVID-19 cases declined and the pandemic accelerated the use of respiratory devices, the studied market is now expected to project stable growth over the studied period. For instance, according to WHO, lung cancer is the leading cause of cancer deaths globally, with smoking responsible for 85% of cases. Early screening of high-risk individuals can improve survival rates, while primary prevention measures, such as tobacco control and reducing environmental risk factors, are crucial in lowering incidence and saving lives.

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The escalating incidence of respiratory disorders worldwide is poised to propel the expansion of the Global Respiratory Endotherapy Devices Market. The rising prevalence of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections is fostering an increased demand for advanced therapeutic interventions. Respiratory endotherapy devices play a pivotal role in the management of these disorders, offering minimally invasive and targeted treatments. For instance, According to the U.S. Centers for Disease Control and Prevention (CDC), smoking is responsible for approximately 8 out of 10 COPD-related deaths. Additionally, increasing levels of indoor and outdoor air pollution, along with exposure to dust and harmful chemicals, are significant contributors to the rising prevalence of COPD. As the global population ages and environmental factors contribute to respiratory health challenges, the need for effective and efficient endotherapy solutions is becoming more pronounced. The market is witnessing a surge in technological innovations, including bronchoscopes, tracheoscopes, and other endoscopic devices, which enhance diagnostic accuracy and treatment precision. Healthcare providers are increasingly adopting these devices to address respiratory issues, contributing to the overall market growth. The growing awareness among patients and healthcare professionals regarding the benefits of endotherapy, such as reduced recovery times and improved patient outcomes, is driving the uptake of these devices. In conclusion, the escalating burden of respiratory disorders, coupled with technological advancements in endotherapy, is anticipated to foster significant growth in the Global Respiratory Endotherapy Devices Market in the coming years.

Key Market Challenges

High Cost of Respiratory Endotherapy Devices

The high cost associated with respiratory endotherapy devices is anticipated to pose a significant impediment to the growth of the Global Respiratory Endotherapy Devices Market. The substantial financial investment required for acquiring these sophisticated medical devices can act as a deterrent for healthcare institutions, particularly in regions with constrained healthcare budgets. The intricate technology and specialized materials involved in manufacturing respiratory endotherapy devices contribute to their elevated price point, limiting accessibility for certain healthcare facilities and hindering widespread adoption. The financial burden on patients seeking respiratory treatments may curb patient acceptance and usage. High device costs often translate to increased procedural expenses, potentially affecting reimbursement policies and posing challenges for both healthcare providers and patients. Market players need to address these cost-related concerns through strategic initiatives such as research and development aimed at cost reduction, exploring partnerships for shared investments, and advocating for favorable reimbursement policies. Mitigating the economic barriers associated with respiratory endotherapy devices is crucial for fostering market growth and ensuring broader access to these advanced medical solutions in the evolving landscape of respiratory healthcare.

Key Market Trends

Advancements in Minimally Invasive Technologies

The growth trajectory of the Global Respiratory Endotherapy Devices Market is poised to be significantly steered by continual advancements in minimally invasive technologies. As medical science evolves, there is a paradigm shift towards procedures that offer reduced patient trauma, shorter recovery times, and enhanced precision. Respiratory endotherapy devices are at the forefront of this transformative trend, providing cutting-edge solutions for the diagnosis and treatment of respiratory disorders with minimal invasiveness. Innovations in endoscopic technologies, including the development of high-definition imaging and advanced navigation systems, empower healthcare practitioners to conduct intricate respiratory procedures with unprecedented clarity and accuracy. The integration of robotics and artificial intelligence further augments the capabilities of respiratory endotherapy devices, enabling more precise interventions and personalized treatment strategies. This technological evolution not only enhances the efficacy of respiratory procedures but also contributes to increased patient acceptance. As the global healthcare landscape embraces these advancements, the demand for state-of-the-art respiratory endotherapy devices is expected to rise, driving market growth. In essence, the continual refinement of minimally invasive technologies is a pivotal catalyst propelling the expansion of the Global Respiratory Endotherapy Devices Market, shaping the future of respiratory healthcare.

Key Market Players

• Fujifilm Holdings Corporation.
• Medtronic plc.
• Johnson & Johnson.
• Smith & Nephew Plc.
• Stryker corporation.
• Olympus corporation.
• Hoya corporation.
• Steris Healthcare.
• Conmed corporation.
• Boston Scientific corporation.

Report Scope:

In this report, the Global Respiratory Endotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Endotherapy Devices Market, By Devices:

• Diagnostic Devices
• Therapeutic Devices

Respiratory Endotherapy Devices Market, By End User:

• Peripheral Vascular Intervention
• Endovascular Interventions
• Cardiac
• Interventional Radiology
• Venous
• Others

Respiratory Endotherapy Devices Market, By Specialist:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

Respiratory Endotherapy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Endotherapy Devices Market.

Available Customizations:

Global Respiratory Endotherapy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Endotherapy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 5.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 5.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 5.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 5.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Devices
• 5.3.2 By End User
• 5.3.3 By Specialist
• 5.3.4 By Region

6. North America Respiratory Endotherapy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 6.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 6.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 6.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 6.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Endotherapy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Devices
      • 6.3.1.2.2. By End User
      • 6.3.1.2.3. By Specialist
  • 6.3.2. Canada Respiratory Endotherapy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Devices
      • 6.3.2.2.2. By End User
      • 6.3.2.2.3. By Specialist
  • 6.3.3. Mexico Respiratory Endotherapy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Devices
      • 6.3.3.2.2. By End User
      • 6.3.3.2.3. By Specialist

7. Europe Respiratory Endotherapy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 7.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 7.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 7.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 7.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Respiratory Endotherapy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Devices
      • 7.3.1.2.2. By End User
      • 7.3.1.2.3. By Specialist
  • 7.3.2. Germany Respiratory Endotherapy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Devices
      • 7.3.2.2.2. By End User
      • 7.3.2.2.3. By Specialist
  • 7.3.3. United Kingdom Respiratory Endotherapy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Devices
      • 7.3.3.2.2. By End User
      • 7.3.3.2.3. By Specialist
  • 7.3.4. Italy Respiratory Endotherapy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Devices
      • 7.3.4.2.2. By End User
      • 7.3.4.2.3. By Specialist
  • 7.3.5. Spain Respiratory Endotherapy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Devices
      • 7.3.5.2.2. By End User
      • 7.3.5.2.3. By Specialist

8. Asia-Pacific Respiratory Endotherapy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 8.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 8.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 8.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 8.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Respiratory Endotherapy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Devices
      • 8.3.1.2.2. By End User
      • 8.3.1.2.3. By Specialist
  • 8.3.2. India Respiratory Endotherapy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Devices
      • 8.3.2.2.2. By End User
      • 8.3.2.2.3. By Specialist
  • 8.3.3. Japan Respiratory Endotherapy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Devices
      • 8.3.3.2.2. By End User
      • 8.3.3.2.3. By Specialist
  • 8.3.4. South Korea Respiratory Endotherapy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Devices
      • 8.3.4.2.2. By End User
      • 8.3.4.2.3. By Specialist
  • 8.3.5. Australia Respiratory Endotherapy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Devices
      • 8.3.5.2.2. By End User
      • 8.3.5.2.3. By Specialist

9. South America Respiratory Endotherapy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 9.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 9.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 9.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 9.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Respiratory Endotherapy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Devices
      • 9.3.1.2.2. By End User
      • 9.3.1.2.3. By Specialist
  • 9.3.2. Argentina Respiratory Endotherapy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Devices
      • 9.3.2.2.2. By End User
      • 9.3.2.2.3. By Specialist
  • 9.3.3. Colombia Respiratory Endotherapy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Devices
      • 9.3.3.2.2. By End User
      • 9.3.3.2.3. By Specialist

10. Middle East and Africa Respiratory Endotherapy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 10.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 10.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 10.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 10.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Respiratory Endotherapy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Devices
      • 10.3.1.2.2. By End User
      • 10.3.1.2.3. By Specialist
  • 10.3.2. Saudi Arabia Respiratory Endotherapy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Devices
      • 10.3.2.2.2. By End User
      • 10.3.2.2.3. By Specialist
  • 10.3.3. UAE Respiratory Endotherapy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Devices
      • 10.3.3.2.2. By End User
      • 10.3.3.2.3. By Specialist

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Respiratory Endotherapy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fujifilm Holdings Corporation.
  • 15.1.1. Business Overview
  • 15.1.2. Product Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Medtronic plc.
• 15.3. Johnson & Johnson.
• 15.4. Smith & Nephew Plc.
• 15.5. Stryker corporation.
• 15.6. Olympus corporation.
• 15.7. Hoya corporation.
• 15.8. Steris Healthcare.
• 15.9. Conmed corporation.
• 15.10. Boston Scientific corporation.

16. Strategic Recommendations

17. About Us & Disclaimer